Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moskowitz

Showing results (171-180 of 298) with videos related to

Pageof 30
Sort By:
Leukemia & Lymphoma|July 26, 2021
Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trialSteven Horwitz, Pier Luigi Zinzani, Martine Bagot, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|February 1, 2018
A Multisite, Multidisciplinary Delphi Consensus Study Describing "Usual Care" Intervention Strategies for School-Age to Transition-Age Youth With AutismConnor M Kerns, Lauren J Moskowitz, Tamara Rosen, et al.
Head & Neck|April 19, 2013
Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapyJohn R de Almeida, Nathaniel L Villanueva, Alan J Moskowitz, et al.
Circulation. Cardiovascular Quality and Outcomes|May 15, 2014
Impact of socioeconomic status measures on hospital profiling in New York CityAlexander B Blum, Natalia N Egorova, Eugene A Sosunov, et al.
Journal of the American College of Cardiology|November 23, 2019
Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve SurgeryGil Moskowitz, Kimberly N Hong, Gennaro Giustino, et al.
Head & Neck|December 10, 2014
Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysisJohn R de Almeida, Alan J Moskowitz, Brett A Miles, et al.
Cancers|January 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) TrialErel Joffe, Anita Kumar, Joseph M Tuscano, et al.
JAMA|October 29, 1997
Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly peopleJ E Sisk, A J Moskowitz, W Whang, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 27, 1999
Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995J A Sollano, A C Gelijns, A J Moskowitz, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Pageof 30

Showing results (171-180 of 298) with videos related to

Sort By:
Pageof 30
Leukemia & Lymphoma|July 26, 2021
Lack of impact of type and extent of prior therapy on outcomes of mogamulizumab therapy in patients with cutaneous T cell lymphoma in the MAVORIC trialSteven Horwitz, Pier Luigi Zinzani, Martine Bagot, et al.
Journal of Clinical Child and Adolescent Psychology : the Official Journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53|February 1, 2018
A Multisite, Multidisciplinary Delphi Consensus Study Describing "Usual Care" Intervention Strategies for School-Age to Transition-Age Youth With AutismConnor M Kerns, Lauren J Moskowitz, Tamara Rosen, et al.
Head & Neck|April 19, 2013
Preferences and utilities for health states after treatment for oropharyngeal cancer: transoral robotic surgery versus definitive (chemo)radiotherapyJohn R de Almeida, Nathaniel L Villanueva, Alan J Moskowitz, et al.
Circulation. Cardiovascular Quality and Outcomes|May 15, 2014
Impact of socioeconomic status measures on hospital profiling in New York CityAlexander B Blum, Natalia N Egorova, Eugene A Sosunov, et al.
Journal of the American College of Cardiology|November 23, 2019
Incidence and Risk Factors for Permanent Pacemaker Implantation Following Mitral or Aortic Valve SurgeryGil Moskowitz, Kimberly N Hong, Gennaro Giustino, et al.
Head & Neck|December 10, 2014
Cost-effectiveness of transoral robotic surgery versus (chemo)radiotherapy for early T classification oropharyngeal carcinoma: A cost-utility analysisJohn R de Almeida, Alan J Moskowitz, Brett A Miles, et al.
Cancers|January 28, 2026
Phase I Study of Mogamulizumab in Combination with Pembrolizumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma-A National Cancer Institute Experimental Therapeutics Clinical Trials Network (NCI-ETCTN) TrialErel Joffe, Anita Kumar, Joseph M Tuscano, et al.
JAMA|October 29, 1997
Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly peopleJ E Sisk, A J Moskowitz, W Whang, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 27, 1999
Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995J A Sollano, A C Gelijns, A J Moskowitz, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 10, 2025
Skin Response to Mogamulizumab in Patients With Mycosis Fungoides and Sezary Syndrome: A Retrospective, Real World CohortRachel E Christensen, Robert Stuver, Stephen Dusza, et al.
Pageof 30